Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionCirculating tumor cells in breast cancer: a tool whose time has come of ageExpression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsCirculating tumor cells: approaches to isolation and characterizationThe Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor CellsStem cell technology in breast cancer: current status and potential applicationsCancer stem cells (CSCs), cervical CSCs and targeted therapiesMinimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsInteraction between circulating cancer cells and platelets: clinical implicationCirculating cancer stem cells: the importance to selectAldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsMetastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor CellsMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersBone metastases: When and how lung cancer interacts with boneEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaMetastatic cancer stem cells: from the concept to therapeuticsDynamic changes in numbers and properties of circulating tumor cells and their potential applicationsEpithelial-mesenchymal plasticity in carcinoma metastasisSheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionEmerging technologies for CTC detection based on depletion of normal cellsMinimal residual disease and circulating tumor cells in breast cancerCirculating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchProgress in circulating tumor cell capture and analysis: implications for cancer managementCirculating tumor cells in the diagnosis and management of pancreatic cancerGlucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cellsCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionDissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackThe Challenges of Detecting Circulating Tumor Cells in SarcomaAKT-ions with a TWIST between EMT and METConcise Review: Stem Cells in Pancreatic Cancer: From Concept to TranslationEMT, CTCs and CSCs in tumor relapse and drug-resistanceUsing circulating tumor cells to inform on prostate cancer biology and clinical utilityEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditionsThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisThe Regulatory Role of MicroRNAs in EMT and CancerSingle cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell linesMolecular biomarker analyses using circulating tumor cellsLabel-free single-cell separation and imaging of cancer cells using an integrated microfluidic system.
P2860
Q21129293-6953D8A0-2DFF-4E53-9A52-499F00832F9AQ21245253-E7969167-A3A1-4911-96D0-0F87A8C5A790Q21284707-F820107A-32B0-44FE-9ADF-9B368D7E6E48Q24631347-91627BC2-55B2-464A-9116-2C5998F3D9F6Q26741223-3E0CEE96-9D1F-477C-AFE4-4A69B5CA6043Q26746223-A62EAC76-0ADA-4761-A3FD-DB4A4810C7A0Q26747144-3451CBC1-827E-4545-A113-0F1EAF5D85EDQ26748850-09A2093D-CBF2-4E00-A367-13038EA3AFFEQ26778920-B8B2284C-6E40-436E-8203-1D074554DA6DQ26778924-2E757BE4-92F5-4636-8AA0-08470612BD6BQ26786476-5058A3E0-0531-4790-8F72-4D292783D0E1Q26796595-7825DA92-CD63-4583-89D1-143A143A52AEQ26797232-43B9288B-A755-4C49-A8D4-4B8DC6D1BDE1Q26822406-010C779B-A9C4-4CF5-820F-AFD7BEBED624Q26823287-4760A422-FD8C-42AF-8162-0F8EC63672E8Q26849546-C3821EC8-1833-4EE2-80DC-9CD0FADA4CA1Q26850739-E4572C3F-04A8-466B-B35B-C2974B669699Q26853569-9C2500F8-32E8-46F3-ADBC-FB2B7777C2CFQ26859804-63DD4615-1F5C-489E-A34F-1C04A541288DQ26864979-A7A3CF81-61A7-41BB-8007-E66AD4BB683CQ27009519-64AB05C2-E0D3-475B-BB2A-3FB9D69B79B5Q27010152-9CEBEF6E-5B5A-4216-A608-BCCD0DD20E2DQ27024191-D11D1BE5-588E-4437-BB97-357D4658829AQ27025737-51110CED-FB6D-4A5F-A554-5110F8CAC6C3Q27027711-7B0FC399-4D6B-4D0C-895B-70D37FC67F34Q27345982-886C23A9-4626-4645-BB03-67A9E09DF8D8Q28066285-3A9DF0F7-0878-4913-A9E1-DB85F884C928Q28067549-212C8D9F-DC8D-4129-BC17-3392E95A6291Q28078659-EC51BD7C-C0CA-406C-9A5D-21E8EE011687Q28078987-BD2E5C89-069C-4218-AB86-85C384A3BD3DQ28081553-5376233F-8275-4B45-9803-5CEA04C07FD0Q28082935-B714B625-3AFE-4CFE-999A-961E3B67AA0EQ28083261-6F3A977F-E4B1-47F8-B4EF-D46B28E0C34CQ28087055-4B735892-A7B1-4EF2-894B-4B4981CE91AEQ28250164-8EC3E0A1-C0C8-418B-AC48-1A9B7E9C926FQ28388257-FF43AC76-E10C-4717-B49A-01EC98D443A0Q28391426-2D06903B-F643-4E1B-A25E-AC11CC50B203Q28483475-1ADC3374-B4AD-43AD-81AE-DD6FD350CE6FQ28749394-9CE75665-204C-4352-AA50-F28E55A14020Q30358279-DE321FDC-05CC-472F-B770-A7E61C7C7142
P2860
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stem cell and epithelial-mesen ...... static breast cancer patients.
@en
Stem cell and epithelial-mesen ...... static breast cancer patients.
@nl
type
label
Stem cell and epithelial-mesen ...... static breast cancer patients.
@en
Stem cell and epithelial-mesen ...... static breast cancer patients.
@nl
prefLabel
Stem cell and epithelial-mesen ...... static breast cancer patients.
@en
Stem cell and epithelial-mesen ...... static breast cancer patients.
@nl
P2093
P2860
P50
P356
P1476
Stem cell and epithelial-mesen ...... static breast cancer patients.
@en
P2093
Mitra Tewes
Rainer Kimmig
Siegfried Hauch
P2860
P2888
P356
10.1186/BCR2333
P577
2009-07-09T00:00:00Z
P5875
P6179
1000606439